Taking a cue from the SEC: Wall Street whistleblowers need anonymity in addition to awards
Rebecca Katz

In a recent speech given at the New York University School of Law, U.S. Attorney General Eric Holder stated that the funds awarded to Wall Street whistleblowers under the Financial Institutions Reform, Recovery and Enforcement Act (FIRREA) should be raised … Continue reading

Generic Drug Labeling: Brand-name drug manufacturers can be held liable for warnings on generic versions
Fred Thompson

The controversial Wyeth v. Weeks decision, which was confirmed by the Alabama Supreme Court this past August 15, 2014, provided a welcome ray of hope in a preemption landscape made desolate by the Mensing decision of 2011. In a salient … Continue reading

Morcellator warning only the latest reason FDA should consider revising the 510(k) process
Carmen Scott

When the FDA released a safety communication earlier this year about the laparoscopic power morcellation (LPM) procedure, many women may have been shocked to learn that this fairly common procedure for removing supposedly benign uterine fibroids could result in the … Continue reading

Is there a link between talcum powder and cancer?
Carmen Scott

While studies continue to examine talcum powder and ovarian cancer, women of all ages should be aware that concerns about the possible relationship between the genital application of talcum powder and ovarian cancer are starting to gain attention. Research studies … Continue reading

Fifth Circuit soundly rules – but BP wrench-throwing continues
Joe Rice

Next week will mark eight months since claims payments through the Deepwater Horizon Settlement’s Business Economic Loss program were halted due to an October 2013 Fifth Circuit Court of Appeals ruling in which Judge Barbier was instructed to craft a … Continue reading